PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership
PatentVest, a division of MDB Capital Holdings (NASDAQ: MDBH), has announced the appointment of Dr. Sarah Cork as Senior Patent Attorney. Dr. Cork brings over a decade of experience in biotechnology, pharmaceutical, and medical device intellectual property matters, complemented by a Ph.D. in Neuroscience.
Dr. Cork specializes in complex IP matters including recombinant technology, biologics, immunotherapies, gene therapy, and AI-enabled precision medicine. Her expertise spans patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses, with significant experience in BPCIA cases and Hatch-Waxman matters.
Beyond her legal practice, Dr. Cork serves as President of the Los Angeles Intellectual Property Law Association and is active in the Pasadena Angels investor group and SBIR grant review process.
PatentVest, una divisione di MDB Capital Holdings (NASDAQ: MDBH), ha annunciato la nomina della Dott.ssa Sarah Cork come Senior Patent Attorney. La Dott.ssa Cork porta oltre dieci anni di esperienza in proprietà intellettuale legata a biotecnologie, farmacologia e dispositivi medici, completata da un dottorato di ricerca in Neuroscienze.
La Dott.ssa Cork è specializzata in questioni IP complesse tra cui tecnologia ricombinante, biologici, immunoterapie, terapia genica e medicina di precisione abilitata dall'IA. La sua competenza comprende controversie brevettuali, prosecuzione, due diligence IP e analisi di freedom-to-operate, con significativa esperienza in casi BPCIA e questioni Hatch-Waxman.
Oltre alla pratica legale, la Dott.ssa Cork è Presidente dell'Los Angeles Intellectual Property Law Association e partecipa attivamente al Pasadena Angels gruppo di investitori e al processo di revisione dei finanziamenti SBIR.
PatentVest, una división de MDB Capital Holdings (NASDAQ: MDBH), ha anunciado la incorporación de la Dra. Sarah Cork como Abogada Senior de Patentes. La Dra. Cork aporta más de una década de experiencia en propiedad intelectual relacionada con biotecnología, farmacéutica y dispositivos médicos, complementada con un Ph.D. en Neurociencias.
La Dra. Cork se especializa en asuntos de IP complejos, incluyendo tecnología recombinante, biológicos, inmunoterapias, terapia génica y medicina de precisión impulsada por IA. Su experiencia abarca litigio de patentes, prosecución de patentes, due diligence de IP y análisis de libertad para operar, con experiencia significativa en casos BPCIA y asuntos Hatch-Waxman.
Más allá de su práctica legal, la Dra. Cork es Presidenta de la Los Angeles Intellectual Property Law Association y participa activamente en el grupo de inversores Pasadena Angels y en el proceso de revisión de subvenciones SBIR.
PatentVest는 MDB Capital Holdings(NASDAQ: MDBH)의 사업부로, Dr. Sarah Cork를 선임 특허 변호사로 발표했습니다. Cork 박사는 생명공학, 의약품 및 의료기기 지적 재산권 관련 문제에서 10년이 넘는 경험과 신경과학 박사 학위를 가지고 있습니다.
Cork 박사는 재조합 기술, 생물학적 제재, 면역 치료법, 유전자 치료 및 AI 기반 정밀 의학을 포함한 복합 지적 재산권 문제를 전문으로 합니다. 특허 소송, 특허 취득 절차, IP 실사 및 운용 자유 분석에 대한 전문 지식을 갖추고 있으며 BPCIA 사건 및 해치-왁스맨(Hatch-Waxman) 이슈에서 상당한 경험이 있습니다.
법적 실무를 넘어, Cork 박사는 로스앤젤레스 지적 재산권 법협회 회장을 역임하고 Pasadena Angels 투자 그룹과 SBIR 보조금 심사 프로세스에 적극적으로 참여하고 있습니다.
PatentVest, une division de MDB Capital Holdings (NASDAQ: MDBH), a annoncé la nomination de la Dr Sarah Cork au poste d'Avocate principale en brevets. La Dr Cork apporte plus d'une décennie d'expérience dans la propriété intellectuelle en biotechnologie, pharmacie et dispositifs médicaux, complétée par un doctorat en neurosciences.
Elle se spécialise dans des questions IP complexes, notamment les technologies recombinantes, les biologiques, les immunothérapies, la thérapie génique et la médecine de précision assistée par l'IA. Son expertise couvre le contentieux des brevets, la poursuite des brevets, la due diligence IP et les analyses de liberté d'exploitation, avec une expérience significative dans les affaires BPCIA et les questions Hatch-Waxman.
En dehors de sa pratique juridique, Dr Cork est présidente de l'Los Angeles Intellectual Property Law Association et est active dans le groupe d'investisseurs Pasadena Angels et dans le processus d'examen des subventions SBIR.
PatentVest, eine Abteilung von MDB Capital Holdings (NASDAQ: MDBH), hat die Ernennung von Dr. Sarah Cork zur Senior Patent Attorney bekannt gegeben. Dr. Cork bringt mehr als ein Jahrzehnt Erfahrung im Bereich geistiges Eigentum in Biotechnologie, Pharmazie und medizinische Geräte mit, ergänzt durch einen Ph.D. in Neurowissenschaften.
Sie spezialisiert sich auf komplexe IP-Angelegenheiten, einschließlich rekombinanter Technologien, Biologika, Immuntherapien, Gentherapie und KI-gestützte Präzisionsmedizin. Ihre Expertise umfasst Patentstreitigkeiten, Patentanmeldungen, IP-Due Diligence und Freedom-to-Operate-Analysen, mit bedeutender Erfahrung in BPCIA-Fällen und Hatch-Waxman-Angelegenheiten.
Neben ihrer juristischen Praxis ist Dr. Cork Präsidentin der Los Angeles Intellectual Property Law Association und aktiv im Pasadena Angels-Investorengruppe sowie im SBIR-Zuschussprüfungsverfahren.
PatentVest، قسم من MDB Capital Holdings (NASDAQ: MDBH)، أعلن تعيين الدكتورة سارة كورك كمحامية براءات رئيسية. تجلب الدكتورة كورك أكثر من عقد من الخبرة في قضايا الملكية الفكرية المتعلقة بالتكنولوجيا الحيوية والصناعات الدوائية والأجهزة الطبية، إلى جانب درجة الدكتوراه في علم الأعصاب.
تتخصص الدكتورة كورك في مسائل الملكية الفكرية المعقدة بما في ذلك التكنولوجيا المحوّرة، والبيولوجيات، والعلاجات المناعية، والعلاج الجيني، والطب الدقيق المدعوم بالذكاء الاصطناعي. تمتد خبرتها إلى رفع براءات الاختراع، ومتابعة براءات الاختراع، والتدقيق في الملكية الفكرية، وتحليلات الحرية في التشغيل، مع خبرة كبيرة في قضايا BPCIA ومشاكل Hatch-Waxman.
بعيداً عن الممارسة القانونية، تشغل الدكتورة كورك منصب رئيسة رابطة قانون الملكية الفكرية في لوس أنجلوس وهي نشطة في مجموعة المستثمرين Pasadena Angels وعملية مراجعة منح SBIR.
PatentVest，隶属于 MDB Capital Holdings（纳斯达克股票代码：MDBH），宣布任命Sarah Cork博士为高级专利律师。Cork博士在生物技术、制药和医疗器械知识产权领域拥有十余年的经验，并获得神经科学博士学位。
Cork博士专注于复杂的知识产权事务，包括重组技术、生物制药、免疫治疗、基因治疗以及由人工智能驱动的精准医疗。她的专长涵盖专利诉讼、专利申请、知识产权尽职调查以及自由实施分析，在BPCIA案件和Hatch-Waxman事务方面具有丰富经验。
在法律实务之外，Cork博士还担任洛杉矶知识产权法协会主席，并活跃于帕萨迪纳天使投资人小组及SBIR资助评审过程。
- Strengthens company's life sciences IP expertise with addition of experienced senior patent attorney
- Expands service capabilities in high-value areas including biologics, gene therapy, and AI-enabled precision medicine
- Enhances ability to handle complex patent litigation and regulatory matters
- None.
Sarah Cork Ph.D. - Patent Attorney
Dallas, TX, Sept. 24, 2025 (GLOBE NEWSWIRE) -- PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is pleased to announce that Dr. Sarah Cork is collaborating with the firm as a Senior Patent Attorney. Her arrival underscores PatentVest’s continued growth in the life sciences sector and strengthens its ability to deliver sophisticated intellectual property strategies that drive competitive advantage for clients.
Dr. Cork brings more than a decade of experience advising biotechnology, pharmaceutical, and medical device companies on complex intellectual property matters. With a Ph.D. in Neuroscience, she counsels clients on a wide range of sophisticated issues involving recombinant technology, biologic and small-molecule drugs, immunotherapies, gene therapy, medical devices, and AI-enabled precision medicine, with a focus on translational drug discovery. Her legal practice combines scientific expertise with extensive experience in patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses. She has advised clients ranging from venture-backed startups developing first-in-class therapies to global enterprises defending multibillion-dollar portfolios.
Dr. Cork’s cases under the Biologics Price Competition and Innovation Act (BPCIA), early at-risk launches. Her litigation background also spans Hatch-Waxman (ANDA) matters, post-grant proceedings, patent inventorship disputes, and drug product liability cases.
“Sarah’s arrival is a major win for our clients,” said Javier Chamorro, COO of PatentVest. “Her unique combination of deep scientific knowledge and proven litigation experience equips us to guide innovators through the most complex IP challenges—from protecting groundbreaking biologics to navigating regulatory pathways. Adding Sarah to our team strengthens PatentVest’s position as a trusted partner for life sciences companies and aligns with our broader mission to build enduring value for our clients and stakeholders.”
Beyond her legal practice, Dr. Cork is an active leader in the intellectual property and life sciences communities. She currently serves as the President of the Los Angeles Intellectual Property Law Association, is a member of the Pasadena Angels investor group, contributes as an SBIR grant reviewer, and entrepreneurs in life sciences incubators and accelerators.
About PatentVest
PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and deep technical expertise, PatentVest delivers actionable insights that protect innovation and empower clients to build lasting market leadership.
For more information or inquiries, please contact info@patentvest.com.
Attachment
FAQ
Who is Dr. Sarah Cork and what is her new role at PatentVest (NASDAQ: MDBH)?
What areas of expertise does Dr. Cork bring to PatentVest (NASDAQ: MDBH)?
What leadership roles does Dr. Cork hold outside of PatentVest?
How will Dr. Cork's appointment impact PatentVest's services?
